New York City based Dracen Pharmaceuticals is raising $17,046,698.00 in New Equity Investment.
New York, NY – According to filings with the U.S. Securities and Exchange Commission, Dracen Pharmaceuticals is raising $17,046,698.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tom Estok played…